DEDICATE DOUBLE-BLIND EVALUATION OF DAPAGLIFLOZIN ON THE INCIDENCE OF CARDIOVASCULAR-ASSOCIATED EVENTS
DEAD
Serial Number
85525589
Owner
BRISTOL-MYERS SQUIBB COMPANYAttorney
Marilyn F. KellyFiling Date
Jan 26, 2012
DEDICATE DOUBLE-BLIND EVALUATION OF DAPAGLIFLOZIN ON THE INCIDENCE OF CARDIOVASCULAR-ASSOCIATED EVENTS Trademark
Serial Number: 85525589
DEDICATE DOUBLE-BLIND EVALUATION OF DAPAGLIFLOZIN ON THE INCIDENCE OF CARDIOVASCULAR-ASSOCIATED EVENTS is a trademark filed by
BRISTOL-MYERS SQUIBB COMPANY
on January 26, 2012. The trademark is classified under Class 42 (Computer & Scientific).
The application is currently no longer active.
Trademark Classes
Owner Contact Info
Legal Representation
Trademark Details
Filing Date
January 26, 2012
Registration Date
Not Registered
Goods & Services
Medical and scientific research, namely, conducting clinical trials and clinical studies relating to pharmaceutical preparations for human use
Filing History
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Dec 14, 2012 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Dec 14, 2012 ABN2
ASSIGNED TO EXAMINER
Jul 10, 2012 DOCK
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 18, 2012 GNRN
NON-FINAL ACTION E-MAILED
May 18, 2012 GNRT
NON-FINAL ACTION WRITTEN
May 18, 2012 CNRT
ASSIGNED TO EXAMINER
May 5, 2012 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 30, 2012 NWOS
NEW APPLICATION ENTERED
Jan 30, 2012 NWAP
